Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2016" report to their offering.

Renal anemia is a disease in which the patient has an unusually low count of red blood cells. Renal is a term that means of the kidneys, so anemia is often associated with kidney disease. This type of anemia is caused by a lack of erythropoietin, a protein produced in the kidneys that helps to create red blood cells. Symptoms caused by renal anemia include pale skin and gums, become short of breath, dizziness and inability to think clearly.

This report provides comprehensive information on the therapeutic development for Anemia in Chronic Kidney Disease (Renal Anemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anemia in Chronic Kidney Disease (Renal Anemia) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Anemia in Chronic Kidney Disease (Renal Anemia) Overview
  3. Therapeutics Development
  4. Pipeline Products for Anemia in Chronic Kidney Disease (Renal Anemia) - Overview
  5. Pipeline Products for Anemia in Chronic Kidney Disease (Renal Anemia) - Comparative Analysis
  6. Anemia in Chronic Kidney Disease (Renal Anemia) - Therapeutics under Development by Companies
  7. Anemia in Chronic Kidney Disease (Renal Anemia) - Therapeutics under Investigation by Universities/Institutes
  8. Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Anemia in Chronic Kidney Disease (Renal Anemia) - Products under Development by Companies
  13. Anemia in Chronic Kidney Disease (Renal Anemia) - Products under Investigation by Universities/Institutes
  14. Anemia in Chronic Kidney Disease (Renal Anemia) - Companies Involved in Therapeutics Development

Companies Mentioned:

  • 3SBio Inc
  • Acceleron Pharma Inc
  • Aevi Genomic Medicine Inc
  • Akebia Therapeutics Inc
  • Amgen Inc
  • Bayer AG
  • Biocad
  • CCM Duopharma Biotech Bhd
  • Chong Kun Dang Pharmaceutical Corp
  • CJ HealthCare Corp
  • (10+ Others)

For more information about this report visit http://www.researchandmarkets.com/research/qdhs3r/anemia_in_chronic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Hematological Drugs, Liver and Kidney Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Hematological Drugs, Liver and Kidney Disorders Drugs